Lower SES Linked to More Advanced Renal Cancer

Share this content:
Lower socioeconomic status linked with larger tumors, higher T stage, positive lymph nodes.
Lower socioeconomic status linked with larger tumors, higher T stage, positive lymph nodes.

ORLANDO—Lower socioeconomic status (SES) is associated with more advanced kidney cancer and poorer outcomes, researchers reported at the American Urological Association 2014 annual meeting.

Using the Surveillance, Epidemiology and End Results (SEER) registry, Matthew Danzig, MD, and colleagues at Columbia University in New York studied kidney cancer patient data from 2001-2010. They examined tumor size and stage at presentation, overall survival rate, and county-level socioeconomic status. They identified 89,632 cases of kidney cancer.

RELATED: Renal Cell Carcinoma Resource Center

Using a socioeconomic index that measured median income, percentage of population living in poverty, and percentage of high school graduates per county, lower SES was a significant predictor of larger tumor size, higher stage, and positive nodal status, but it was not a significant predictor of metastasis at diagnosis.

Lower SES also significantly predicted shorter overall survival when controlling for other factors such as race, gender and age.

“Therefore, it can be inferred that improved access to healthcare is a form of screening that results in a greater likelihood of incidental detection of kidney cancer,” the researchers concluded in their study abstract.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs